Financial Year |
March 31 2023 |
Monetary Funds |
27,040,490,007.31 |
Held-for-trading Financial Assets |
11,069,131,143.25 |
Notes Receivable |
1,392,602,573.15 |
Accounts Receivable |
74,889,839,253.65 |
Advances to Suppliers |
5,615,816,099.73 |
Other Receivables |
2,461,918,036.27 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
54,058,025.13 |
Inventories |
32,147,922,901.52 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
161,663,554.22 |
Other Current Assets |
832,586,860.88 |
Total Current Assets |
157,170,379,297.84 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
204,349,642.80 |
Long-term Equity Investment |
9,399,302,765.44 |
Investment Properties |
225,929,641.08 |
Fixed Assetes |
11,389,327,284.48 |
Under-construction Projects |
3,166,963,224.09 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
135,143,149.25 |
Oil and Gas Assets |
-- |
Intangible Assets |
6,110,167,521.49 |
R&D expenses |
337,966,185.04 |
Goodwill |
11,334,049,532.07 |
Long-Term Deferred and Prepaid Expenses |
473,156,550.76 |
Deferred Income Tax Assets |
1,548,366,925.10 |
Other Non-Current Assets |
403,792,866.76 |
Sub-Total of Non-Current Assets |
48,865,419,982.59 |
Total Assets |
206,035,799,280.43 |
Short-Term Loans |
32,318,083,153.00 |
Trading Financial liabilities |
-- |
Notes Payable |
6,199,842,236.69 |
Accounts Payable |
47,311,519,105.68 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
1,153,659,606.43 |
Taxes Payable |
1,273,633,414.65 |
Interest Payable |
-- |
Dividend Payable |
278,016,660.21 |
Other payables |
15,735,904,924.23 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,129,027,173.24 |
Other Current Liabilities |
6,213,349,723.59 |
Sub-Total of Current Liabilities |
114,301,935,555.32 |
Long-term Loans |
8,596,134,663.56 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
8,440,638.86 |
Special Payable |
-- |
Estimatied Liabilities |
24,005,518.40 |
Deferred Income Tax Liabilities |
983,167,003.58 |
Other Non-Current Liabilities |
237,788,627.89 |
Sub-Total of Non-Current Liabilities |
11,852,996,832.91 |
Total Liabilities |
126,154,932,388.23 |
Paid-In Capital(Or Share Stock) |
3,698,499,159.00 |
Capital Surplus |
29,114,509,187.93 |
Surplus Reserve |
2,158,807,271.16 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
33,997,521,665.56 |
Minority Stockholder's Interest |
11,313,409,273.87 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
68,567,457,618.33 |
Owner's Equity(Stockholder's Equity) |
79,880,866,892.20 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
206,035,799,280.43 |